Fabrizio Buffolo Selected Research

Hypertension (High Blood Pressure)

12/2023	Long-Term Follow-Up of Patients With Elevated Aldosterone-to-Renin Ratio but Negative Confirmatory Test: The Progression of Primary Aldosteronism Phenotypes.
3/2021	Quality of life in primary aldosteronism: A prospective observational study.
1/2021	Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
1/2021	Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement.
6/2020	Primary Aldosteronism and Obstructive Sleep Apnea: Casual Association or Pathophysiological Link?
1/2020	Renin-Angiotensin-Aldosterone System Triple-A Analysis for the Screening of Primary Aldosteronism.
1/2020	The spectrum of low-renin hypertension.
1/2020	Use of Steroid Profiling Combined With Machine Learning for Identification and Subtype Classification in Primary Aldosteronism.
10/2018	Diagnostic approach to low-renin hypertension.
1/2018	Primary aldosteronism in the primary care setting.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabrizio Buffolo Research Topics

Disease

16	Hyperaldosteronism (Conn Syndrome) 12/2023 - 01/2014
12	Hypertension (High Blood Pressure) 12/2023 - 09/2016
7	Adenoma (Adenomas) 01/2020 - 01/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 06/2020
3	Calcinosis 01/2021 - 05/2018
3	Hyperplasia 03/2018 - 04/2017
2	Inflammation (Inflammations) 01/2022 - 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2023
1	Disease Progression 01/2023
1	Hypertrophy 01/2022
1	Myocardial Infarction 01/2022
1	Pathologic Processes 01/2022
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Heart Failure 01/2022
1	Atrial Fibrillation 01/2022
1	Vascular Calcification 01/2021
1	Atherosclerosis 01/2021
1	Rupture 01/2021
1	Sleep Apnea Syndromes (Sleep Apnea) 06/2020
1	Obstructive Sleep Apnea 06/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2020
1	Obesity 06/2020
1	Hypokalemia 01/2020
1	Essential Hypertension 01/2020
1	Apnea 12/2019
1	Ischemia 12/2018
1	Familial Hyperaldosteronism 03/2018

Drug/Important Bio-Agent (IBA)

15	AldosteroneIBA 12/2023 - 01/2014
9	ReninIBA 12/2023 - 05/2016
3	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 04/2017
3	PotassiumIBA 01/2022 - 01/2020
3	HydrogelsIBA 01/2021 - 05/2018
2	Antihypertensive Agents (Antihypertensives)IBA 03/2021 - 01/2021
2	CollagenIBA 01/2021 - 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2023
1	MetanephrineIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023
1	ProteomeIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	SodiumIBA 01/2022
1	CytokinesIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2021
1	Diphosphonates (Bisphosphonates)IBA 01/2021
1	ElementsIBA 01/2021
1	Ibandronic Acid (Boniva)FDA Link 01/2021
1	MineralsIBA 01/2021
1	CanrenoneIBA 01/2021
1	Annexin A1IBA 01/2020
1	SteroidsIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 12/2018
1	ElectrolytesIBA 10/2018
1	Cosyntropin (Cortrosyn)FDA LinkGeneric 05/2017
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2014
1	GTP-Binding Proteins (G-Protein)IBA 01/2014

Therapy/Procedure

4	Therapeutics 01/2021 - 04/2017
3	Adrenalectomy 01/2022 - 04/2017
1	Aftercare (After-Treatment) 01/2020